Wednesday’s Daily Piece: Novel Renal Indication for Invokana

This week, FDA has approved an additional novel indication for canagliflozin (Invokana) for persons with type 2 diabetes and diabetes related kidney disease. Specifically, canagliflozin is now indicated to reduce worsening kidney function, risk of end stage renal disease, cardiovascular death and heart failure hospitalization in adults living with type 2 diabetes and kidney disease. Wow! Please click below to learn more.

https://www.medscape.com/viewarticle/919184?nlid=131848_3901&src=wnl_newsalrt_190930_MSCPEDIT&uac=293412PG&impID=2113721&faf=1

This image has an empty alt attribute; its file name is image-6.jpeg

Please share your thoughts and subscribe to receive my blogs.

#canagliflozin #novel #kidney #indication

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.

Leave a Reply

Your email address will not be published. Required fields are marked *